VIR Biotech Insider Buys 42,377 Shares in Confidence Move Amid Earnings Beat and New Astellas Partnership
Vir Biotechnology’s insider buying surge signals confidence in a new PSMA‑targeting partnership and earnings beat, hinting at future upside.
4 minutes to read

